SEC Form 4 · accession 0001104659-18-066047
NOVELION THERAPEUTICS INC. · NVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Benjamin Harshbarger
Officer — General Counsel
Period of report
May 9, 2018
Accepted (ET)
Nov 5, 2018 · 6:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 9, 2018 | F | 322 | $4.26 | D | 4,143 | D | |
| Common StockF1 | May 15, 2018 | F | 150 | $4.15 | D | 3,993 | D | |
| Common StockF1 | Sep 17, 2018 | F | 98 | $3.94 | D | 3,895 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to the vesting of restricted stock units.